• Work With Us
    • Partnerships
      • We offer tailored partnerships to support and transform drug discovery.

        Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

    • Services
      • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

        As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

    • OrganoReady®
      • Our OrganoReady program is made for you when you need defined assays in ADME.

        We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Resources & Support
    • Knowledge Center
      • Get inspired by peer-reviewed publications, webinars, whitepapers, app notes and more in our knowledge center.

    • Blogs
      • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
    • Case Studies
      • Get inspired by research done by our scientists, partners, and customers around the globe.

    • Webinars & Events
    • Applications
  • About MIMETAS
  • News
  • We offer tailored partnerships to support and transform drug discovery.

    Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

  • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

    As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

  • Our OrganoReady program is made for you when you need defined assays in ADME.

    We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Get inspired by peer-reviewed publications, webinars, whitepapers, app notes and more in our knowledge center.

  • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
open menu icon close menu icon
EN

Jos Joore

 

This interview is part of a series of conversations with the people working at Mimetas. The 'I' in Mimetas focuses on the personal side of the people that drive our world. Today we have a chat with Jos Joore, CEO and co-founder of Mimetas.

What small things in life make you happy?

That's an interesting one. I would say it's, in particular, the small things that make me happy. Being out in nature, taking a run, being with family. People need a firm, happy basis to cope with challenges like setting up and running a company. That basis is made up of all the small things in life that are, in fact, the most important.

What is different in how you thought Mimetas would be and what Mimetas has become?

At the start, around 2010, Paul Vulto and I had many ideas for applying microfluidics in life sciences, but organ-on-a-chip wasn't one of them. It took us a few years to develop the concept of culturing cells and tissues in 3D microfluidic devices. From that time on, we had a pretty clear picture of the way forward for Mimetas. We want to empower research on complex tissue biology and work towards therapy development and personalized medicine. I would say that the concepts of Mimetas have stayed mostly the same over the years, but the order of priorities has changed. In the early days, we weren't thinking a lot about drug development yet. But over time, we have learned that we add tremendous value to the research of pharmaceutical companies. That is why we're now focusing more and more on drug development collaborations using disease-relevant biological models in OrganoPlate.

What is the biggest motivator in your work?

I could say it is to cure cancer or some other lofty goal - which is obviously very important – but that does not work for me on a day-to-day basis. My biggest motivator is working with great colleagues, enabling us to be our best selves. I always try to put colleagues in the right place, surrounded by the right people. That's it. All the big goals follow once everyone feels happy, knows what to do, and performs best.

Which of your failures has had the most impact on your career?

Before starting Mimetas, I tried setting up a company four times, beginning in 2003. Three failed, the fourth resulted in the incorporation of Pepscope in 2012, a company that has now attracted its first investment. These attempts were learning experiences and primed me to go all-in for Mimetas, avoiding some of the obvious mistakes.

What makes you optimistic about the future?

I strongly believe in people's ingenuity and perseverance, especially when faced with challenging, urgent issues. It's only worrying that it seems that the world's biggest problems need to be right in our face before people take action. But once that happens, I'm convinced that we can tackle almost every situation. Except for, let's say, a giant rock crashing into the earth tomorrow.

What is your favorite quote, song, or belief, anything that you live by?

That would be the three main improvisation theatre rules: make other people shine, say "yes, and…" to input and ideas, and do not be afraid to make mistakes. They are fundamental and widely applicable in life. Trying to follow these guidelines makes you a more positive person, capable of handling change and coping with challenges. Every day, I try to live by these three rules as much as I can.

 

Cookies

‘May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below. Terms of Use & Privacy Policy

Accept all
Accept selected
Decline all